PDF(Pubmed)
Abstract：
Evaluations of technology to help adults manage type 2 diabetes (T2D) have yielded mixed results. We analyzed the effectiveness of a free app linked to a glucose meter to study reductions in glucose levels over time among a self-selected sample of adults with T2D.
Adults with T2D >12 months, >21 years, ability to read English (insulin using-IU and non-insulin using-NIU) who independently elected to pair their CONTOUR NEXT ONE meter with the CONTOUR DIABETES App were invited to participate. Glucose data from baseline to 16 weeks were uploaded to the cloud (N = 461). Assessment of diabetes distress, medication taking, quality of life, and hypoglycemia concerns occurred at baseline, six, and 16 weeks.
Findings indicated a significant decrease in weekly glucose levels over time: baseline mean = 169 (62.0) (9.4 mmol/L; 3.44); 16-week mean = 146.5 (36.0) (8.1 mmol/L; 2.0) (P < .001), with no IU and NIU differences. Largest reductions occurred during the first six weeks, with no later rebound effects. Significant, though modest, improvements in global quality of life (P = .03), hypoglycemia concerns (P = .01), and diabetes distress (P < .001) occurred over 16 weeks.
Making an App for monitoring glucose easily available for download with a glucose meter can be helpful for self-selected adults with T2D. Effective utilization assumes that users are sufficiently motivated and engaged, are comfortable and trusting of the technology, and have sufficient knowledge of how to make use of the glucose data.
Adults with T2D >12 months, >21 years, ability to read English (insulin using-IU and non-insulin using-NIU) who independently elected to pair their CONTOUR NEXT ONE meter with the CONTOUR DIABETES App were invited to participate. Glucose data from baseline to 16 weeks were uploaded to the cloud (N = 461). Assessment of diabetes distress, medication taking, quality of life, and hypoglycemia concerns occurred at baseline, six, and 16 weeks.
Findings indicated a significant decrease in weekly glucose levels over time: baseline mean = 169 (62.0) (9.4 mmol/L; 3.44); 16-week mean = 146.5 (36.0) (8.1 mmol/L; 2.0) (P < .001), with no IU and NIU differences. Largest reductions occurred during the first six weeks, with no later rebound effects. Significant, though modest, improvements in global quality of life (P = .03), hypoglycemia concerns (P = .01), and diabetes distress (P < .001) occurred over 16 weeks.
Making an App for monitoring glucose easily available for download with a glucose meter can be helpful for self-selected adults with T2D. Effective utilization assumes that users are sufficiently motivated and engaged, are comfortable and trusting of the technology, and have sufficient knowledge of how to make use of the glucose data.
摘要：
未经评估：帮助成年人管理2型糖尿病（T2D）的技术评估结果好坏参半。我们分析了与血糖仪相关的免费应用程序的有效性，以研究自选的T2D成人样本中葡萄糖水平随时间的降低。
未经批准：患有T2D>12个月的成年人，>21年,阅读英语的能力（使用-IU的胰岛素和使用-NIU的非胰岛素）独立选择将其轮廓下一个仪表与轮廓糖尿病应用程序配对的人被邀请参加。将从基线到16周的葡萄糖数据上传到云(N=461)。评估糖尿病的困扰，服药,生活质量,和低血糖的担忧发生在基线，六,16周。
UNASSIGNED：研究结果表明，随着时间的推移，每周血糖水平显着下降：基线平均值=169（62.0）（9.4mmol/L；3.44）；16周平均值=146.5（36.0）（8.1mmol/L；2.0）（P<.001），没有IU和NIU的差异。最大的减少发生在前六周，没有后期反弹效应。重要的,虽然谦虚，全球生活质量的改善（P=0.03），低血糖问题（P=0.01），和糖尿病困扰（P<.001）发生超过16周。
UNASSIGNED：使用血糖仪轻松下载用于监测葡萄糖的应用程序可能对自行选择的T2D成人有所帮助。有效利用假设用户有足够的积极性和参与度，对技术感到舒适和信任，并且对如何利用葡萄糖数据有足够的了解。
未经批准：患有T2D>12个月的成年人，>21年,阅读英语的能力（使用-IU的胰岛素和使用-NIU的非胰岛素）独立选择将其轮廓下一个仪表与轮廓糖尿病应用程序配对的人被邀请参加。将从基线到16周的葡萄糖数据上传到云(N=461)。评估糖尿病的困扰，服药,生活质量,和低血糖的担忧发生在基线，六,16周。
UNASSIGNED：研究结果表明，随着时间的推移，每周血糖水平显着下降：基线平均值=169（62.0）（9.4mmol/L；3.44）；16周平均值=146.5（36.0）（8.1mmol/L；2.0）（P<.001），没有IU和NIU的差异。最大的减少发生在前六周，没有后期反弹效应。重要的,虽然谦虚，全球生活质量的改善（P=0.03），低血糖问题（P=0.01），和糖尿病困扰（P<.001）发生超过16周。
UNASSIGNED：使用血糖仪轻松下载用于监测葡萄糖的应用程序可能对自行选择的T2D成人有所帮助。有效利用假设用户有足够的积极性和参与度，对技术感到舒适和信任，并且对如何利用葡萄糖数据有足够的了解。
